Table 1.

Baseline Characteristics of a Cohort of Men Newly Diagnosed With Prostate Cancer, Overall and by Use of Androgen Deprivation Therapy, United Kingdom, 1988–2014

Characteristic	Entire Cohort		Androgen Deprivation Therapya
	No.	%	Use		No Use
			No.	%	No.	%
Total	31,842		16,599	52.1	15,243	47.9
Age, yearsb	71.4 (8.9)		73.3 (8.4)		69.4 (9.0)
Smoking status
Current smoker	3,838	12.1	2,099	12.7	1,739	11.4
Past smoker	11,328	35.6	6,186	37.3	5,142	33.7
Never smoker	15,038	47.2	7,469	45.0	7,569	49.7
Unknown	1,638	5.1	845	5.1	793	5.2
Body mass indexc
<30 (nonobese)	22,676	71.2	11,747	70.8	10,929	71.7
≥30 (obese)	5,063	15.9	2,712	16.3	2,351	15.4
Unknown	4,103	12.9	2,140	12.9	1,963	12.9
Prostate-specific antigen level, ng/mL
<10	10,260	32.2	2,877	17.3	7,383	48.4
≥10	13,205	41.5	9,342	56.3	3,863	25.3
Unknown	8,377	26.3	4,380	26.4	3,997	26.2
Nonsteroidal antiinflammatory drug use	3,891	12.2	2,185	13.2	1,706	11.2

^a Use of androgen deprivation therapy in the first 6 months of follow-up.

^b Values are expressed as mean (standard deviation).

^c Weight (kg)/height (m)².